University of Texas MD Anderson Cancer Center:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C9035)
◆英語タイトル:University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review
◆商品コード:DATA904C9035
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

University of Texas MD Anderson Cancer Center – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson provides cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Oct 21,2018: Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer
Sep 13,2018: Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases
Sep 10,2018: Study links BAP1 protein to tumor suppression in kidney, eye, bile duct and mesothelioma cancers
Aug 24,2018: $50 million awarded by CPRIT to MD Anderson and its projects
Aug 06,2018: Comprehensive CAR t-cell therapy pediatric guidelines developed by MD Anderson in collaboration with the pediatric acute lung injury and sepsis investigators network

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
University of Texas MD Anderson Cancer Center – Key Facts 5
University of Texas MD Anderson Cancer Center – Key Employees 6
University of Texas MD Anderson Cancer Center – Key Employee Biographies 7
University of Texas MD Anderson Cancer Center – Major Products and Services 8
University of Texas MD Anderson Cancer Center – History 9
University of Texas MD Anderson Cancer Center – Company Statement 16
University of Texas MD Anderson Cancer Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Section 2 – Company Analysis 20
Company Overview 20
University of Texas MD Anderson Cancer Center – Business Description 21
University of Texas MD Anderson Cancer Center – Corporate Strategy 22
University of Texas MD Anderson Cancer Center – SWOT Analysis 23
SWOT Analysis – Overview 23
University of Texas MD Anderson Cancer Center – Strengths 23
University of Texas MD Anderson Cancer Center – Weaknesses 24
University of Texas MD Anderson Cancer Center – Opportunities 25
University of Texas MD Anderson Cancer Center – Threats 26
University of Texas MD Anderson Cancer Center – Key Competitors 27
Section 3 – Company’s Lifesciences Financial Deals and Alliances 28
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
University of Texas MD Anderson Cancer Center, Recent Deals Summary 30
Section 4 – Company’s Recent Developments 31
Oct 21, 2018: Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer 31
Sep 13, 2018: Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases 32
Sep 10, 2018: Study links BAP1 protein to tumor suppression in kidney, eye, bile duct and mesothelioma cancers 33
Aug 24, 2018: $50 million awarded by CPRIT to MD Anderson and its projects 34
Aug 06, 2018: Comprehensive CAR t-cell therapy pediatric guidelines developed by MD Anderson in collaboration with the pediatric acute lung injury and sepsis investigators network 35
Jul 17, 2018: Therapeutics Discovery drug impairs cancer cells growth and survival 36
Jul 17, 2018: Therapeutics Discovery drug impairs cancer cells growth and survival 39
Jul 12, 2018: Study shows biomarker panel boosts lung cancer risk assessment for smokers 42
Jul 12, 2018: Blood test can help identify the target population to screen for lung cancer 44
Jul 02, 2018: OncLive Presents the Latest State of the Science Summit on Breast Cancer 45
Section 5 – Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
University of Texas MD Anderson Cancer Center, Key Facts 5
University of Texas MD Anderson Cancer Center, Key Employees 6
University of Texas MD Anderson Cancer Center, Key Employee Biographies 7
University of Texas MD Anderson Cancer Center, Major Products and Services 8
University of Texas MD Anderson Cancer Center, History 9
University of Texas MD Anderson Cancer Center, Other Locations 17
University of Texas MD Anderson Cancer Center, Subsidiaries 18
University of Texas MD Anderson Cancer Center, Joint Venture 18
University of Texas MD Anderson Cancer Center, Key Competitors 27
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
University of Texas MD Anderson Cancer Center, Recent Deals Summary 30

List of Figures
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ University of Texas MD Anderson Cancer Center:企業の戦略的SWOT分析(University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆